Renaissance Technologies’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,366
Closed -$732K 3912
2024
Q4
$732K Sell
25,366
-23,900
-49% -$690K ﹤0.01% 2652
2024
Q3
$1.17M Sell
49,266
-10,900
-18% -$259K ﹤0.01% 2345
2024
Q2
$1.04M Buy
60,166
+13,300
+28% +$230K ﹤0.01% 2297
2024
Q1
$1.05M Sell
46,866
-36,156
-44% -$808K ﹤0.01% 2460
2023
Q4
$1.52M Buy
83,022
+45,251
+120% +$830K ﹤0.01% 2121
2023
Q3
$656K Buy
37,771
+2,900
+8% +$50.4K ﹤0.01% 2581
2023
Q2
$635K Buy
34,871
+2,271
+7% +$41.4K ﹤0.01% 2740
2023
Q1
$559K Sell
32,600
-14,525
-31% -$249K ﹤0.01% 2826
2022
Q4
$1.1M Sell
47,125
-27,442
-37% -$638K ﹤0.01% 2481
2022
Q3
$1.66M Sell
74,567
-37,904
-34% -$841K ﹤0.01% 2150
2022
Q2
$2.17M Buy
+112,471
New +$2.17M ﹤0.01% 2129